• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL0700052 Eltrombopag olamine片 eltrombopag olamine Tablet Chemical Drugs(1.1) Import Drug Application 2007-03-22 依格斯(北京)医疗科技有限公司 Excel Pharma Studies Inc;Smithkline Beecham Corporation Certificate Issued 2007-11-29 view
CXHL1500783 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2015-06-10 泰州云峰医药科技有限公司 Taizhou Yunfeng Pharmaceutical Technology Co Ltd Certificate Issued 2016-08-12 view
CXHL1400266 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-03-19 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2016-02-19 view
CXHL1500323 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2015-06-05 合肥新格医药科技有限公司 Hefei Xinge Medical Technology Co Ltd Certificate Issued 2016-08-12 view
CXHL1502366 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2016-03-18 杭州和泽医药科技有限公司 Zhejiang Heze Pharmaceutical Technology Co Ltd Certificate Issued 2017-03-15 view
CXHL1402024 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2015-02-10 江西施美制药有限公司 Jiangxi Shimei Pharmaceutical Co Ltd Certificate Issued 2016-05-19 view
CXHL1400392 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-05-04 江苏奥赛康药业股份有限公司 Jiangsu Aosaikang Pharmaceutical Co Ltd Certificate Issued 2016-03-01 view
CXHL1401447 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-10-30 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-03-28 view
CXHL1401288 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-09-25 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2016-03-17 view
CXHL1402132 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2015-02-27 瑞阳制药有限公司 Reyoung Pharmaceutical Co Ltd Certificate Issued 2016-05-19 view
CXHL1401341 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2015-01-19 北京蓝贝望生物医药科技股份有限公司 Labworld Bio-Medicine Technology Corp ltd Certificate Issued 2016-05-19 view
CXHL1401458 艾曲泊帕乙醇胺 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-03-28 view
CYHS2500908 艾曲泊帕乙醇胺干混悬剂 eltrombopag olamine Suspension Chemical Drugs(3) Generic Drug 2025-03-04 Hubei Minkang Pharmaceutical Group Co Ltd;Nanjing Healthnice Pharmaceutical Co Ltd view
CYHS2403244 艾曲泊帕乙醇胺干混悬剂 eltrombopag olamine Suspension Chemical Drugs(3) Generic Drug 2024-09-26 Nanjing Healthnice Pharmaceutical Co Ltd;Nanjing Siling Pharmaceutical Technology Co Ltd view
CYHS2303319 艾曲泊帕乙醇胺干混悬剂 eltrombopag olamine Suspension Chemical Drugs(3) Generic Drug 2023-11-30 Shandong Zezheng Pharmaceutical Technology Co Ltd;Hunan Jiudian Pharmaceutical Co Ltd view
CYHS2500700 艾曲泊帕乙醇胺干混悬剂 eltrombopag olamine Suspension Chemical Drugs(3) Generic Drug 2025-02-12 Zhengzhou Taifeng Pharmaceutical Co Ltd view
CYHS2404528 艾曲泊帕乙醇胺干混悬剂 eltrombopag olamine Suspension Chemical Drugs(3) Generic Drug 2024-12-26 Guangzhou Lianrui Pharmaceutical Co Ltd view
JYHB2200024 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2022-01-14 Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG view
JYHB2000988 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2020-06-25 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Filed 2020-06-29 view
CXHL1401459 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view